Thase M E, Brent D A, Neil J F, Horn T L
Gen Hosp Psychiatry. 1985 Jan;7(1):43-8. doi: 10.1016/0163-8343(85)90009-x.
Use of the DST was studied in medically hospitalized, depressed patients. Although complicating medical factors necessarily excluded nearly 60% of referrals, post-dexamethasone plasma cortisol values were significantly higher in 14 major depressives appropriate for the DST as compared to 12 patients with milder, subsyndromal depressive conditions. Using a plasma cortisol criterion of greater than 7 micrograms/dl, the DST identified major depression with 57% sensitivity and 92% specificity in this subsample (p less than 0.005). While limited by a high exclusion rate, the DST may be useful for confirmation of major depression in carefully screened general hospital patients. Implications for research and practice are discussed.
在因医学原因住院的抑郁症患者中对地塞米松抑制试验(DST)的应用进行了研究。尽管复杂的医学因素必然排除了近60%的转诊患者,但与12例症状较轻、亚综合征性抑郁状态的患者相比,适合进行DST的14例重度抑郁症患者的地塞米松后血浆皮质醇值显著更高。使用血浆皮质醇标准大于7微克/分升,DST在该子样本中识别重度抑郁症的敏感性为57%,特异性为92%(p<0.005)。虽然受到高排除率的限制,但DST可能有助于在经过仔细筛选的综合医院患者中确诊重度抑郁症。讨论了对研究和实践的影响。